Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the KORA F4/FF4 study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The objective of the present study was to identify proteins that contribute to pathophysiology and allow prediction of incident type 2 diabetes or incident prediabetes. We quantified 14 candidate proteins using targeted mass spectrometry in plasma samples of the prospective, population-based German KORA F4/FF4 study (6.5-year follow-up). 892 participants aged 42-81 years were selected using a case-cohort design, including 123 persons with incident type 2 diabetes and 255 persons with incident WHO-defined prediabetes. Prospective associations between protein levels and diabetes, prediabetes as well as continuous fasting and 2 h glucose, fasting insulin and insulin resistance were investigated using regression models adjusted for established risk factors. The best predictive panel of proteins on top of a non-invasive risk factor model or on top of HbA1c, age, and sex was selected. Mannan-binding lectin serine peptidase (MASP) levels were positively associated with both incident type 2 diabetes and prediabetes. Adiponectin was inversely associated with incident type 2 diabetes. MASP, adiponectin, apolipoprotein A-IV, apolipoprotein C-II, C-reactive protein, and glycosylphosphatidylinositol specific phospholipase D1 were associated with individual continuous outcomes. The combination of MASP, apolipoprotein E (apoE) and adiponectin improved diabetes prediction on top of both reference models, while prediabetes prediction was improved by MASP plus CRP on top of the HbA1c model. In conclusion, our mass spectrometric approach revealed a novel association of MASP with incident type 2 diabetes and incident prediabetes. In combination, MASP, adiponectin and apoE improved type 2 diabetes prediction beyond non-invasive risk factors or HbA1c, age and sex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Targeted MS methods have been developed, again especially where interferences obfuscate immunoassays128 or where additional biological context is required129.”
From A high-stringency blueprint of the human proteome (2020) · cites this paper as [129]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
mice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966 · cited 1×
“Type 2 diabetes causes an enormous burden for the individual as well as for societies of many countries worldwide [1].”
BackgroundDiagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Nordestgaard, B. G., Langsted, A., Mora, S., Kolovou, G., Baum, H., Bruckert, E., Watts, G. F., Sypniewska, G., Wiklund, O., Borén, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw152 · Cited by 847 · cited 1×
“The main advantage of HbA1c in contrast to glucose is its spontaneous availability, avoiding fasting, which is no longer required in routine clinical practice [18], and avoiding oral glucose tolerance test (OGTT) burden [19].”
BackgroundSelf-citationGall, W. E., Beebe, K., Lawton, K. A., Adam, K.-P., Mitchell, M. W., Nakhle, P. J., Ryals, J. A., Milburn, M. V., Nannipieri, M., Camastra, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010883 · Cited by 698 · cited 1×
“Research on type 2 diabetes risk stratification either aims at diagnosis of insulin resistance or prediabetes [6, 7] or attempts to directly predict the future risk of diabetes [7–10].”
BackgroundLiu, C., Feng, X., Li, Q., Wang, Y., Li, Q., & Hua, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.028 · Cited by 470
Schulze, M. B., Hoffmann, K., Boeing, H., Linseisen, J., Rohrmann, S., Möhlig, M., Pfeiffer, A. F. H., Spranger, J., Thamer, C., Häring, H.-U., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2089 · Cited by 372
Research works printed but not linked: 1
- WHO. Global report on diabetes. Geneva, Switzerland: WHO Press; 2006.
Cited by
Objectives, design and main findings until 2020 from the Rotterdam Study
Ikram, M. A., Brusselle, G., Ghanbari, M., Goedegebure, A., Ikram, M. K., Kavousi, M., Kieboom, B. C. T., Klaver, C. C. W., de Knegt, R. J., Luik, A. I., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00640-5 · Cited by 452
Petrera, A., von Toerne, C., Behler, J., Huth, C., Thorand, B., Hilgendorff, A., & Hauck, S. M. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00641 · Cited by 216
Self-citationA high-stringency blueprint of the human proteome
Adhikari, S., Nice, E. C., Deutsch, E. W., Lane, L., Omenn, G. S., Pennington, S. R., Paik, Y.-K., Overall, C. M., Corrales, F. J., Cristea, I. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19045-9 · Cited by 210
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Gadd, D. A., Hillary, R. F., Kuncheva, Z., Mangelis, T., Cheng, Y., Dissanayake, M., Admanit, R., Gagnon, J., Lin, T., Ferber, K. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00655-7 · Cited by 142
Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
Fang, X., Miao, R., Wei, J., Wu, H., & Tian, J. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.10.030 · Cited by 125
“identified proteins related to the prediction and early diagnosis of T2DM [100].”
BackgroundAlzheimer’s disease and type 2 diabetes mellitus: A systematic review of proteomic studies
Pereira, J. D., Fraga, V. G., Santos, A. L. M., Ferriani, M. D. G. C., Caramelli, P., & Gomes, K. B. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15166 · Cited by 110
“…et al., 2017; Dey et al., 2019; Dincer et al., 2009; Fania et al., 2017; Gómez-Cardona et al., 2017; González-Sánchez et al., 2008; Hu et al., 2012; Huth et al., 2019; Hye et al., 2006; IJsselstijn et al., 2011; Jensen et al., 2013; Kitamura et al., 2017; Li et al., 2008, 2018; Liu et al., 2006,…”
Multi-omics profiling: the way toward precision medicine in metabolic diseases
Hu, C., & Jia, W. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab051 · Cited by 117
Deciphering the Plasma Proteome of Type 2 Diabetes
Elhadad, M. A., Jonasson, C., Huth, C., Wilson, R., Gieger, C., Matías‐García, P. R., Grallert, H., Graumann, J., Gailus‐Durner, V., Rathmann, W., et al. (2020) · Diabetes · doi:10.2337/db20-0296 · Cited by 80
Self-citationLuo, H. L., Bauer, A., Nano, J., Petrera, A., Rathmann, W., Herder, C., Hauck, S. M., Sun, B. B., Hoyer, A., Peters, A., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05943-2 · Cited by 64
“All participants without known diabetes received a standard 75 g OGTT after an overnight fast of at least 8 h [11].”
BackgroundInfluentialSelf-citationPlasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías‐García, P. R., Wilson, R., Guo, Q., Zaghlool, S. B., Eales, J., Xu, X., Charchar, F. J., Dormer, J., Maalmi, H., Schlosser, P., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071070 · Cited by 46
“Validation of Proteomic Targets We examined the plasma levels of proteins measured using Proximity Extension Assay (PEA) technology (Olink) in a subgroup of randomly selected participants from the KORA F4 study (n5173).(37,38) In brief, protein abundance was quantified using real-time PCR in the PEA proteomic technolo…”
Self-citationYao, P., Iona, A., Pozarickij, A., Said, S., Wright, N., Lin, K., Millwood, I. Y., Fry, H., Kartsonaki, C., Mazidi, M., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2145 · Cited by 42
Multi-omics approaches for biomarker discovery and precision diagnosis of prediabetes
Song, J., Wang, C., Zhao, T., Zhang, Y., Xing, J., Zhao, X., Zhang, Y., & Zhang, Z. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1520436 · Cited by 53
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetes
Croyal, M., Wargny, M., Chemello, K., Chevalier, C., Blanchard, V., Bigot‐Corbel, E., Lambert, G. C., May, C. L., Hadjadj, S., & Cariou, B. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01452-5 · Cited by 34
“also found that apoE is positively associated with new-onset diabetes beyond classical risk factors such as HbA1c, age, and sex [44].”
BackgroundMASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19
Bumiller‐Bini, V., Oliveira, C. F., Carvalho, T. M., Kretzschmar, G. C., Gonçalves, L. B., Alencar, N. M., Filho, M. A. G., Beltrame, M. H., & Boldt, A. B. W. (2021) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2020-0199 · Cited by 33
Marttila, S., Viiri, L. E., Mishra, P. P., Kühnel, B., Matías‐García, P. R., Lyytikäinen, L., Ceder, T., Mononen, N., Rathmann, W., Winkelmann, J., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01132-3 · Cited by 31
“Glucose, HDL and LDL cholesterol, triglyceride, HbA1c [68], serum insulin [69], GT, AST, and ALT [70] levels were measured by standardized methods, and non-HDL cholesterol levels were calculated.”
MethodSelf-citationHarnessing Pharmacomultiomics for Precision Medicine in Diabetes: A Comprehensive Review
Dhieb, D., Mustafa, D. N., Hassiba, M., Alasmar, M., Elsayed, M. E. M., Musa, A., Zirie, M. A., & Bastaki, K. (2025) · Biomedicines · doi:10.3390/biomedicines13020447 · Cited by 28
“Proteomics present a valuable tool in understanding the pathogenicity of diseases and the discovery of potential biomarkers such as MASP [71], Ftuin-A [72], and others.”
The Complement System in Metabolic-Associated Kidney Diseases
Xu, Z., Li, T., & Su, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.902063 · Cited by 27
Thorand, B., Zierer, A., Büyüközkan, M., Krumsiek, J., Bauer, A., Schederecker, F., Sudduth-Klinger, J., Meisinger, C., Grallert, H., Rathmann, W., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa953 · Cited by 26
“We included the additional category “unknown” because previous analyses had shown that this group incorporates a higher type 2 diabetes risk, separately from the category “no parental history” (13).”
InfluentialSelf-citationLarge-Scale Proteomics Improve Risk Prediction for Type 2 Diabetes
Xie, R., Vlaški, T., Trares, K., Herder, C., Holleczek, B., Brenner, H., & Schöttker, B. (2025) · Diabetes Care · doi:10.2337/dc24-2478 · Cited by 22
Self-citationThen, C., Herder, C., Then, H. L., Thorand, B., Huth, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa165 · Cited by 20
“Study design, recruitment and eligibility criteria, standardized sampling methods and data collection (medical history, medication, anthropometric and blood pressure measurements) have been described in detail elsewhere [22, 23].”
Self-citationSujana, C., Seißler, J., Jordan, J., Rathmann, W., Köenig, W., Roden, M., Mansmann, U., Herder, C., Peters, A., Thorand, B., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01117-1 · Cited by 19
Self-citationThen, C., Gar, C., Thorand, B., Huth, C., Then, H. L., Meisinger, C., Heier, M., Peters, A., Köenig, W., Rathmann, W., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001425 · Cited by 20
Self-citationWu, X., Xuan, W., You, L., Lian, H., Li, F., Zhang, X., Chen, Q., Sun, K., Chen, C., Xu, M., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02632-1 · Cited by 20
“The recent data obtained from the KORA F4/FF4 study indicated that the association between adiponectin and incidence of diabetes and prediabetes is stronger in males than in females [21].”
Li, Y., Yuan, H., Dai, Z., Zhang, W., Zhang, X., Zhao, B., Liang, Z., Zhang, L., & Zhang, Y. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338343 · Cited by 18
Hallmarks of the metabolic secretome
Reghupaty, S. C., Dall, N. R., & Svensson, K. J. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.09.006 · Cited by 19
Lau, L. H. Y., Nano, J., Cecil, A., Schederecker, F., Rathmann, W., Prehn, C. P., Zeller, T., Lechner, A., Adamski, J., Peters, A., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001951 · Cited by 18
Self-citationIntegrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes
Carrasco-Zanini, J., Pietzner, M., & Langenberg, C. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01340-w · Cited by 15
Circulating Proteome and Progression of Type 2 Diabetes
Gou, W., Yue, L., Tang, X., Wu, Y., Cai, X., Shuai, M., Miao, Z., Fu, Y., Chen, H., Jiang, Z., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac098 · Cited by 14
Pathak, K., Gogoi, U., Saikia, R., Pathak, M. P., & Das, A. (2022) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91097-2.00004-2 · Cited by 16
Huemer, M., Huth, C., Schederecker, F., Klug, S. J., Meisinger, C., Köenig, W., Rathmann, W., Peters, A., & Thorand, B. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001321 · Cited by 14
“28 The OGTT was performed after an overnight fast of at least 8 hours.”
Self-citationLai, L., Juntilla, D. L., Gomez-Alonso, M. D. C., Grallert, H., Thorand, B., Farzeen, A., Rathmann, W., Winkelmann, J., Prokisch, H., Gieger, C., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02558-8 · Cited by 13
“FPG, HbA1c, HOMA-IR, and HOMA-B were assessed as described earlier [25].”
Self-citationGar, C., Thorand, B., Herder, C., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., Roden, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262330 · Cited by 11
“Recruitment and eligibility criteria for the KORA studies, study design, standardized sampling methods and data collection (medical history, medication, anthropometric and blood pressure measurements) have been described elsewhere [31, 32].”
BackgroundSelf-citationThen, C., Ritzel, K., Herder, C., Then, H. L., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002558 · Cited by 9
Self-citationRückert‐Eheberg, I., Steger, A., Müller, A., Linkohr, B., Barthel, P., Maier, M., Allescher, J., Sinner, M. F., Rizas, K. D., Rathmann, W., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318502 · Cited by 8
“Diabetes status was assessed by an oral glucose tolerance test (OGTT) that was performed in all participants without known diabetes as described previously [31] (S1 Table).”
Self-citationStebletsova, A. O., & Torubarova, I. I. (2019) · Vestnik Volgogradskogo gosudarstvennogo universiteta Serija 2 Jazykoznanije · doi:10.15688/jvolsu2.2019.4.12 · Cited by 10
Prediction of diabetic protein markers based on an ensemble method
Qu, K., Zou, Q., & Shi, H. W. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4935 · Cited by 8
“It is one of the common pregnancy complications in obstetrics, and it has serious adverse effects on the health of mothers and babies [19].”
BackgroundLiu, S., Zhu, J., Zhong, H., Wu, C., Xue, H., Darst, B. F., Guo, X., Durda, P., Tracy, R. P., Liu, Y., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06277-3 · Cited by 8
“…proteins have been reported to be associated with type 2 diabetes risk through their measured abundances in blood, including mannan-binding lectin serine peptidase (MASP) [21], adiponectin [21], gelsolin [22] and WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (WFIKKN2) [22].”
Association of serum uromodulin with adipokines in dependence of type 2 diabetes
Then, C., Herder, C., Thorand, B., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., Roden, M., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155786 · Cited by 6
Self-citationLi, J., Zhao, D. H., Liu, J., Wang, M., Sun, J., Liu, J., Li, Y., Deng, Q., & Qi, Y. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-052388 · Cited by 6
Bonnell, J., Alcazar, O., Watts, B. M., Buchwald, P., Abdulreda, M. H., & Ogihara, M. (2024) · Biomedicines · doi:10.3390/biomedicines12030492 · Cited by 7
“To this end, parametric modeling approaches like logistic regression have facilitated the identification of potentially important biomarkers, seen use in diabetes research, and are now established methods in the bioinformatics literature [26–29].”
MethodXi, Y., Breitner-Busch, S., Dong, Q., Wolf, K., Dallavalle, M., Nikolaou, N., Cyrys, J., Grallert, H., Linkohr, B., Rathmann, W., et al. (2026) · Environment International · doi:10.1016/j.envint.2025.110043 · Cited by 4
Self-citationEnțuc, M., Bogdán, M., Boboc, I. K. Ş., Mititelu-Tarțău, L., Reurean‐Pintilei, D., Pavel, L. L., Pelin, A.-M., Spinei, A., & Foia, L. G. (2026) · Medicina · doi:10.3390/medicina62010152 · Cited by 9
“Clinically, GPLD1 can be measured through ELISA or proteomics, enabling non-invasive application [89,95].”
Emerging biomarkers in type 2 diabetes mellitus
Mir, R., Alghamdi, M. A. A., BinAfif, W. F., Alharthi, M. H., Alshahrani, A., Alamri, M. M. S., Alfaifi, J. A., Ameer, A., & Mir, R. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.01.002 · Cited by 3
Association of Aldosterone with Mortality in the General Population
Then, C., Herder, C., Heier, M., Meisinger, C., Köenig, W., Rathmann, W., Sujana, C., Roden, M., Bidlingmaier, M., Seißler, J., et al. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2035-6179 · Cited by 3
“Recruitment and eligibility criteria, study design, standardized sampling methods and data collection (medical history, medication, anthropometric and blood pressure measurements) have been described in detail elsewhere [22].”
BackgroundSelf-citationShi, L. S., Zheng, R., Brunius, C. F., Byberg, L., Baron, J. A., Wolk, A., Michaëlsson, K., & Landberg, R. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.07.015 · Cited by 2
Lipids Abnormality and Type 2 Diabetes Mellitus: Causes and Consequences
Wang, K., & Ahmadizar, F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96592 · Cited by 1
Large-scale multi-omics enhance risk prediction for type 2 diabetes
Xie, R. X., Herder, C., & Schöttker, B. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03223-y · Cited by 2
Self-citationAronow, W. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.87280 · Cited by 1
Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study
Then, C., Sujana, C., Herder, C., Then, H. L., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., Maalmi, H., et al. (2022) · Vascular Health and Risk Management · doi:10.2147/vhrm.s363814 · Cited by 1
“Recruitment and eligibility criteria for the KORA studies, study design, standardized sampling methods and data collection (medical history, medication, anthropometric and blood pressure measurements) have been described in detail elsewhere.(20,21) CT-proET-1 was measured in the first consecutive 1596 participants of…”
MethodSelf-citationThe remarkable similarity in the serum proteome between type 2 diabetics and controlsPreprint
Mosedale, D. E., Sharp, T., de Graff, A. M. R., & Grainger, D. J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.19.585746 · Cited by 1
Brunzell, J. D., & Failor, R. A. (2018) · DeckerMed Medicine · doi:10.2310/fm.1569
Fritsche, A., Icks, A., Schulze, M. B., & Szendrödi, J. (2021) · Diabetes aktuell · doi:10.1055/a-1397-3379
Marttila, S., Viiri, L. E., Mishra, P. P., Kühnel, B., Matías‐García, P. R., Lyytikäinen, L., Ceder, T., Mononen, N., Rathmann, W., Winkelmann, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15041071
Self-citationNi, W., Zhang, S., Herder, C., Breitner, S., Wolf, K., Liao, M., Nikolaou, N., Pickford, R., Köenig, W., Rathmann, W., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c04956
Self-citationThe Gut Microbiome in Pre-Diabetes: Biomarkers, Computational Approaches, and Therapeutic PotentialPreprint
Dharod, A., & Pratapa, T. (2025) · Preprints.org · doi:10.20944/preprints202511.2220.v1
Sujana, C., Seissler, J., Jordan, J., Rathmann, W., Koenig, W., Roden, M., Mansmann, U., Herder, C., Peters, A., Thorand, B., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13106513
Self-citationMarttila, S., Viiri, L. E., Mishra, P. P., Kühnel, B., Matías‐García, P. R., Lyytikäinen, L.-P., Ceder, T., Mononen, N., Rathmann, W., Winkelmann, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15041068
Self-citation
Metadata
- Authors
- Huth, C., von Toerne, C., Schederecker, F., de las Heras Gala, T., Herder, C., Kronenberg, F., Meisinger, C., Rathmann, W., Koenig, W., Waldenberger, M., Roden, M., Peters, A., Hauck, S. M., & Thorand, B.
- Affiliations
- Helmholtz Munich (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Innsbruck Medical University (AT)
- Corresponding author
- Huth, Cornelia
- ORCID
- Venue
- European Journal of Epidemiology
- Published
- 2018-12-31
- Volume
- 34
- Issue
- 4
- Pages
- 409-422
- ISSN
- 0393-2990 (ISSN-L)
- 1573-7284
- PMC
- PMC6451724
- OpenAlex
- W2907303285
- Cited by
- 56
- References
- 44
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 8 · 2021: 14 · 2020: 12 · 2019: 1 · 2018: 1
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- European Journal of Epidemiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Funders
- Bundesministerium für Bildung und Forschung
- Ministerium für Wissenschaft und Forschung Nordrhein-Westfalen
- Bundesministerium für Gesundheit
- Bundesland Bayern
- Munich Center of Health Sciences
- Deutsche Forschungsgemeinschaft (DFG, RA 459/2-1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- type 2 diabetes, prediabetes, plasma protein biomarkers, adiponectin, apolipoprotein E, C-reactive protein, apolipoprotein A-IV, apolipoprotein C-II, diabetes risk prediction, insulin resistance, HbA1c
- MeSH terms
- Adult, Aged, Aged, 80 and over, Apolipoproteins E, Diabetes Mellitus, Type 2, Female, Germany, Humans, Male, Middle Aged, Prediabetic State, Prospective Studies, Risk Factors, Biomarkers, Proteomics, Mannose-Binding Protein-Associated Serine Proteases, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.